Preeclampsia and cognitive impairment later in life

被引:97
|
作者
Fields, Julie A. [1 ]
Garovic, Vesna D. [2 ,3 ]
Mielke, Michelle M. [4 ,5 ]
Kantarci, Kejal [6 ]
Jayachandran, Muthuvel [7 ]
White, Wendy M. [3 ]
Butts, Alissa M. [1 ]
Graff-Radford, Jonathan [5 ]
Lahr, Brian D. [4 ]
Bailey, Kent R. [4 ]
Miller, Virginia M. [7 ,8 ]
机构
[1] Mayo Clin, Dept Psychiat & Psychol, Div Neurocognit Disorders, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Internal Med, Div Nephrol & Hypertens, Rochester, MN USA
[3] Mayo Clin, Div Maternal Fetal Med, Dept Obstet & Gynecol, Rochester, MN USA
[4] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA
[5] Mayo Clin, Dept Neurol, Rochester, MN USA
[6] Mayo Clin, Dept Radiol, Rochester, MN USA
[7] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN USA
[8] Mayo Clin, Dept Surg, Rochester, MN USA
基金
美国国家卫生研究院;
关键词
cardiovascular disease; cerebrovascular disease; cognition; dementia; hypertensive pregnancy; mild cognitive impairment; preeclampsia; CARDIOVASCULAR-DISEASE RISK; ALZHEIMERS-DISEASE; ATHEROSCLEROSIS RISK; POSTMENOPAUSAL WOMEN; VASCULAR DEMENTIA; PREGNANCY; MIDLIFE; BRAIN; HYPERTENSION; HISTORY;
D O I
10.1016/j.ajog.2017.03.008
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
BACKGROUND: Hypertension is a risk factor for cerebrovascular disease and cognitive impairment. Women with hypertensive episodes during pregnancy report variable neurocognitive changes within the first decade following the affected pregnancy. However, long-term follow-up of these women into their postmenopausal years has not been conducted. OBJECTIVE: The aim of this study was to examine whether women with a history of preeclampsia were at increased risk of cognitive decline 35-40 years after the affected pregnancy. STUDY DESIGN: Women were identified and recruited through the medical linkage, population-based Rochester Epidemiologic Project. Forty women with a history of preeclampsia were age-and parity-matched to 40 women with a history of normotensive pregnancy. All women underwent comprehensive neuropsychological assessment and completed self-report inventories measuring mood, ie, depression, anxiety, and other symptoms related to emotional state. Scores were compared between groups. In addition, individual cognitive scores were examined by neuropsychologists and a neurologist blinded to pregnancy status, and a clinical consensus diagnosis of normal, mild cognitive impairment, or dementia for each participant was conferred. RESULTS: Age at time of consent did not differ between preeclampsia (59.2 [range 50.9-71.5] years) and normotensive (59.6 [range 52.1-72.2] years) groups, nor did time fromindex pregnancy (34.9 [range 32.0-47.2] vs 34.5 [range 32.0-46.4] years, respectively). There were no statistically significant differences in raw scores on tests of cognition and mood between women with histories of preeclampsia compared to women with histories of normotensive pregnancy. However, a consensus diagnosis of mild cognitive impairment or dementia trended toward greater frequency in women with histories of preeclampsia compared to those with normotensive pregnancies (20% vs 8%, P = .10) and affected more domains among the preeclampsia group (P = .03), most strongly related to executive dysfunction (d = 1.96) and verbal list learning impairment (d = 1.93). CONCLUSION: These findings suggest a trend for women with a history of preeclampsia to exhibit more cognitive impairment later in life than those with a history of normotensive pregnancy. Furthermore, the pattern of cognitive changes is consistent with that observed with vascular disease/white matter pathology.
引用
收藏
页码:74.e1 / 74.e11
页数:11
相关论文
共 50 条
  • [31] Hypertension and metabolic abnormalities later in life after preeclampsia
    Nohira, Tomoyoshi
    [J]. HYPERTENSION RESEARCH IN PREGNANCY, 2013, 1 (01) : 52 - 56
  • [32] Preeclampsia and health risks later in life: an immunological link
    Cheng, Shi-Bin
    Sharma, Surendra
    [J]. SEMINARS IN IMMUNOPATHOLOGY, 2016, 38 (06) : 699 - 708
  • [33] Preeclampsia and health risks later in life: an immunological link
    Shi-Bin Cheng
    Surendra Sharma
    [J]. Seminars in Immunopathology, 2016, 38 : 699 - 708
  • [34] NEONATAL HANDLING RESCUES LATER-LIFE COGNITIVE IMPAIRMENT PROGRAMMED BY EARLY-LIFE GLUCOCORTICOID TREATMENT
    Claessens, S. E. F.
    Daskalakis, N. P.
    Oitzl, M. S.
    de Kloet, E. R.
    [J]. AGE AND AGEING, 2012, 41 : 47 - 47
  • [35] AGE OF FIRST EXPOSURE TO FOOTBALL AND LATER-LIFE COGNITIVE IMPAIRMENT IN FORMER NFL PLAYERS
    Maroon, Joseph C.
    Bailes, Julian
    Collins, Michael
    Lovell, Mark
    Mathyssek, Christina
    Andrikopoulos, Jim
    Larrabee, Glenn J.
    Rohling, Martin L.
    Binder, Laurence M.
    [J]. NEUROLOGY, 2015, 85 (11) : 1007 - 1008
  • [36] Education as the Great Equalizer? Racial and Ethnic Differences in the Effect of Education on Cognitive Impairment in Later Life
    Sherman-Wilkins, Kyler J.
    Thierry, Amy D.
    [J]. GERIATRICS, 2019, 4 (03)
  • [37] Age of first exposure to football and later-life cognitive impairment in former NFL players
    Stamm, Julie M.
    Bourlas, Alexandra P.
    Baugh, Christine M.
    Fritts, Nathan G.
    Daneshvar, Daniel H.
    Martin, Brett M.
    McClean, Michael D.
    Tripodis, Yorghos
    Stern, Robert A.
    [J]. NEUROLOGY, 2015, 84 (11) : 1114 - 1120
  • [38] Fat intake at midlife and cognitive impairment later in life: a population-based CAIDE study
    Eskelinen, Marjo H.
    Ngandu, Tiia
    Helkala, Eeva-Liisa
    Tuomilehto, Jaakko
    Nissinen, Aulikki
    Soininen, Hilkka
    Kivipelto, Miia
    [J]. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2008, 23 (07) : 741 - 747
  • [39] Placental CpG methylation of infants born extremely preterm predicts cognitive impairment later in life
    Tilley, Sloane K.
    Martin, Elizabeth M.
    Smeester, Lisa
    Joseph, Robert M.
    Kuban, Karl C. K.
    Heeren, Tim C.
    Dammann, Olaf U.
    O'Shea, T. Michael
    Fry, Rebecca C.
    [J]. PLOS ONE, 2018, 13 (03):
  • [40] SOCIAL INEQUITIES AND THE IMPAIRMENT PARADOX IN LATER LIFE
    Engelman, Michal
    Jackson, Heide
    [J]. INNOVATION IN AGING, 2023, 7 : 244 - 244